Methods This study represents a retrospective secondary analysis of routinely collected clinical data
Among those on the 10 mg and 15 mg doses, 50% to 57% lost 20% or more
Oral semaglutide might be preferable for someone focused on blood sugar control and comfortable with pill-based therapy, while injectable semaglutide might be better for someone prioritizing weight loss or concerned about gastrointestinal side effects.[1] The authors conclude that more large-scale real-world studies are needed to confirm these findings and explore whether the newer 2 mg once-weekly injectable dose might offer additional benefits.[1] Sources: [1] Pinto M, Brennan L, Diehl K, Lin S, Heacock S
doi: 10.2165/00023210-200721001-00005 [DOI] [PubMed] [Google Scholar] 17.Notartomaso S, Mascio G, Bernabucci M, et al
Nitric oxide signaling in health and disease
Cell Commun Signal (2020) 18(1):59